Helicore Biopharma: Funding, Investors & Team (Sep 2026)
Helicore Biopharma is leading the way in innovating treatments for obesity and associated conditions.
Helicore Biopharma has raised $65.0M across 1 funding round on record, the most recent a Series A of $65.0M announced in Jan 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Helicore Biopharma Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Helicore Biopharma Funding Rounds
Helicore Biopharma Founders and Leadership Team
No contact details are on record for this team yet.
Helicore Biopharma Funding Compared to Other Biotechnology Startups
Helicore Biopharma's latest round of $65.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Helicore Biopharma in Biotechnology and San Mateo
Companies Similar to Helicore Biopharma
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Helicore Biopharma Funding FAQs
What does Helicore Biopharma do?
Helicore Biopharma is leading the way in innovating treatments for obesity and associated conditions.
How much funding has Helicore Biopharma raised?
Helicore Biopharma has raised $65.0M across 1 round on record. The most recent is a Series A of $65.0M announced in Jan 2025.
When did Helicore Biopharma last raise funding?
Helicore Biopharma's most recent funding round on record is a Series A of $65.0M, announced in Jan 2025.
Who founded Helicore Biopharma?
FundedIQ lists Jing Liang (Founder) at Helicore Biopharma.
Where is Helicore Biopharma headquartered?
Helicore Biopharma is based in San Mateo, California, United States.
How many employees does Helicore Biopharma have?
Helicore Biopharma is in the 1-10 employee band.
How does Helicore Biopharma's funding compare to other Biotechnology startups?
Helicore Biopharma's latest round of $65.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Helicore Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Helicore Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.